HEADER HYDROLASE 06-DEC-17 6F6R TITLE CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH N-{3-[1-((S)-2-HYDROXY-5- TITLE 2 OXO-TETRAHYDRO-FURAN-3-YLCARBAMOYL)-ETHYL]-1-METHYL-2,4-DIOXO-1,2,3, TITLE 3 4-TETRAHYDRO-PYRIMIDIN-5-YL}-4-(QUINOXALIN-2-YLAMINO)-BENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CASP-1,INTERLEUKIN-1 BETA CONVERTASE,IL-1BC,INTERLEUKIN-1 COMPND 5 BETA-CONVERTING ENZYME,IL-1 BETA-CONVERTING ENZYME,P45; COMPND 6 EC: 3.4.22.36; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CASPASE-1; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: CASP-1,INTERLEUKIN-1 BETA CONVERTASE,IL-1BC,INTERLEUKIN-1 COMPND 12 BETA-CONVERTING ENZYME,IL-1 BETA-CONVERTING ENZYME,P45; COMPND 13 EC: 3.4.22.36; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP1, IL1BC, IL1BCE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CASP1, IL1BC, IL1BCE; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CASPASE-1, NANOMOLAR INHIBITOR, INFLAMMATORY DISEASES, SP3 KEYWDS 2 HYBRIDIZATION, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.F.FOURNIER,L.CLARY,S.CHAMBON,L.DUMAIS,C.S.HARRIS,C.MILLOIS-BARBUIS, AUTHOR 2 R.PIERRE,S.TALANO,E.THOREAU,J.AUBERT,M.AURELLY,C.BOUIX-PETER, AUTHOR 3 A.BRETHON,L.CHANTALAT,O.CHRISTIN,C.COMINO,G.EL-BAZBOUZ,A.L.GHILINI, AUTHOR 4 T.ISABET,C.LARDY,A.P.LUZY,C.MATHIEU,K.MEBROUK,D.ORFILA,J.PASCAU, AUTHOR 5 K.REVERSE,D.ROCHE,V.RODESCHINI,L.F.HENNEQUIN REVDAT 2 23-MAY-18 6F6R 1 JRNL REVDAT 1 02-MAY-18 6F6R 0 JRNL AUTH J.F.FOURNIER,L.CLARY,S.CHAMBON,L.DUMAIS,C.S.HARRIS, JRNL AUTH 2 C.MILLOIS,R.PIERRE,S.TALANO,E.THOREAU,J.AUBERT,M.AURELLY, JRNL AUTH 3 C.BOUIX-PETER,A.BRETHON,L.CHANTALAT,O.CHRISTIN,C.COMINO, JRNL AUTH 4 G.EL-BAZBOUZ,A.L.GHILINI,T.ISABET,C.LARDY,A.P.LUZY, JRNL AUTH 5 C.MATHIEU,K.MEBROUK,D.ORFILA,J.PASCAU,K.REVERSE,D.ROCHE, JRNL AUTH 6 V.RODESCHINI,L.F.HENNEQUIN JRNL TITL RATIONAL DRUG DESIGN OF TOPICALLY ADMINISTERED CASPASE 1 JRNL TITL 2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY ACNE. JRNL REF J. MED. CHEM. V. 61 4030 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29648825 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00067 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 32881 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1644 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.86 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.20 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2957 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2410 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2810 REMARK 3 BIN R VALUE (WORKING SET) : 0.2402 REMARK 3 BIN FREE R VALUE : 0.2573 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.97 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 147 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2114 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 253 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.84370 REMARK 3 B22 (A**2) : -4.84370 REMARK 3 B33 (A**2) : 9.68740 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.111 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.107 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.102 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.101 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2263 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3064 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 816 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 54 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 359 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2263 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 300 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2908 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.71 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.81 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* },{ B|* }, REMARK 3 ORIGIN FOR THE GROUP (A): 14.2517 30.1142 -6.9184 REMARK 3 T TENSOR REMARK 3 T11: 0.1569 T22: 0.2003 REMARK 3 T33: 0.1469 T12: -0.0058 REMARK 3 T13: -0.0118 T23: 0.0167 REMARK 3 L TENSOR REMARK 3 L11: 0.6824 L22: 1.0359 REMARK 3 L33: 1.6209 L12: -0.4036 REMARK 3 L13: 0.5372 L23: -0.5502 REMARK 3 S TENSOR REMARK 3 S11: -0.0381 S12: 0.0667 S13: 0.0020 REMARK 3 S21: 0.0718 S22: 0.0450 S23: 0.0554 REMARK 3 S31: -0.1314 S32: -0.1662 S33: -0.0069 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6F6R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-DEC-17. REMARK 100 THE DEPOSITION ID IS D_1200005652. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32900 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 7.140 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.25 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.460 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES (PH7.4), 2 M (NH4)2SO4 AND REMARK 280 25 MM DTT, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.92500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 32.07000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 32.07000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 124.38750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 32.07000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 32.07000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 41.46250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 32.07000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 32.07000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 124.38750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 32.07000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 32.07000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 41.46250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 82.92500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 18230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -125.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 501 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 118 CG CD OE1 NE2 REMARK 470 ASP A 119 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 148 49.92 -151.45 REMARK 500 ALA A 284 136.81 -173.62 REMARK 500 ASP B 336 -15.27 83.67 REMARK 500 ASP B 336 -13.88 83.68 REMARK 500 ASP B 381 65.29 -115.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 765 DISTANCE = 5.97 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CVE A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 502 DBREF 6F6R A 118 297 UNP P29466 CASP1_HUMAN 118 297 DBREF 6F6R B 317 404 UNP P29466 CASP1_HUMAN 317 404 SEQRES 1 A 180 GLN ASP ASN PRO ALA MET PRO THR SER SER GLY SER GLU SEQRES 2 A 180 GLY ASN VAL LYS LEU CYS SER LEU GLU GLU ALA GLN ARG SEQRES 3 A 180 ILE TRP LYS GLN LYS SER ALA GLU ILE TYR PRO ILE MET SEQRES 4 A 180 ASP LYS SER SER ARG THR ARG LEU ALA LEU ILE ILE CYS SEQRES 5 A 180 ASN GLU GLU PHE ASP SER ILE PRO ARG ARG THR GLY ALA SEQRES 6 A 180 GLU VAL ASP ILE THR GLY MET THR MET LEU LEU GLN ASN SEQRES 7 A 180 LEU GLY TYR SER VAL ASP VAL LYS LYS ASN LEU THR ALA SEQRES 8 A 180 SER ASP MET THR THR GLU LEU GLU ALA PHE ALA HIS ARG SEQRES 9 A 180 PRO GLU HIS LYS THR SER ASP SER THR PHE LEU VAL PHE SEQRES 10 A 180 MET SER HIS GLY ILE ARG GLU GLY ILE CYS GLY LYS LYS SEQRES 11 A 180 HIS SER GLU GLN VAL PRO ASP ILE LEU GLN LEU ASN ALA SEQRES 12 A 180 ILE PHE ASN MET LEU ASN THR LYS ASN CYS PRO SER LEU SEQRES 13 A 180 LYS ASP LYS PRO LYS VAL ILE ILE ILE GLN ALA CYS ARG SEQRES 14 A 180 GLY ASP SER PRO GLY VAL VAL TRP PHE LYS ASP SEQRES 1 B 88 ALA ILE LYS LYS ALA HIS ILE GLU LYS ASP PHE ILE ALA SEQRES 2 B 88 PHE CYS SER SER THR PRO ASP ASN VAL SER TRP ARG HIS SEQRES 3 B 88 PRO THR MET GLY SER VAL PHE ILE GLY ARG LEU ILE GLU SEQRES 4 B 88 HIS MET GLN GLU TYR ALA CYS SER CYS ASP VAL GLU GLU SEQRES 5 B 88 ILE PHE ARG LYS VAL ARG PHE SER PHE GLU GLN PRO ASP SEQRES 6 B 88 GLY ARG ALA GLN MET PRO THR THR GLU ARG VAL THR LEU SEQRES 7 B 88 THR ARG CYS PHE TYR LEU PHE PRO GLY HIS HET CVE A 501 41 HET SO4 A 502 5 HETNAM CVE (3~{S})-3-[[(2~{R})-2-[3-METHYL-2,6-BIS(OXIDANYLIDENE)- HETNAM 2 CVE 5-[[4-(QUINOXALIN-2-YLAMINO) HETNAM 3 CVE PHENYL]CARBONYLAMINO]PYRIMIDIN-1-YL]PROPANOYL]AMINO]- HETNAM 4 CVE 4-OXIDANYL-BUTANOIC ACID HETNAM SO4 SULFATE ION FORMUL 3 CVE C27 H27 N7 O7 FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *253(H2 O) HELIX 1 AA1 SER A 137 SER A 149 1 13 HELIX 2 AA2 ALA A 150 ILE A 152 5 3 HELIX 3 AA3 GLY A 181 LEU A 196 1 16 HELIX 4 AA4 THR A 207 HIS A 220 1 14 HELIX 5 AA5 ARG A 221 SER A 227 5 7 HELIX 6 AA6 GLN A 257 ASN A 266 1 10 HELIX 7 AA7 CYS A 270 LYS A 274 5 5 HELIX 8 AA8 VAL B 348 ALA B 361 1 14 HELIX 9 AA9 ASP B 365 PHE B 377 1 13 SHEET 1 AA1 6 SER A 199 LYS A 204 0 SHEET 2 AA1 6 LEU A 164 CYS A 169 1 N ILE A 167 O LYS A 203 SHEET 3 AA1 6 THR A 230 MET A 235 1 O VAL A 233 N ILE A 168 SHEET 4 AA1 6 LYS A 278 GLN A 283 1 O ILE A 281 N LEU A 232 SHEET 5 AA1 6 PHE B 327 CYS B 331 1 O ILE B 328 N ILE A 280 SHEET 6 AA1 6 THR B 388 GLU B 390 -1 O GLU B 390 N ALA B 329 SHEET 1 AA2 2 ILE A 243 CYS A 244 0 SHEET 2 AA2 2 ILE A 255 LEU A 256 -1 O LEU A 256 N ILE A 243 SHEET 1 AA3 2 ARG B 341 HIS B 342 0 SHEET 2 AA3 2 GLY B 346 SER B 347 -1 O GLY B 346 N HIS B 342 LINK SG CYS A 285 C36 CVE A 501 1555 1555 1.75 SITE 1 AC1 18 ASP A 119 PRO A 121 ARG A 179 GLN A 283 SITE 2 AC1 18 CYS A 285 HOH A 605 HOH A 642 HOH A 669 SITE 3 AC1 18 HOH A 718 SER B 339 TRP B 340 ARG B 341 SITE 4 AC1 18 HIS B 342 MET B 345 GLY B 346 SER B 347 SITE 5 AC1 18 VAL B 348 ARG B 383 SITE 1 AC2 8 ILE A 239 ARG A 240 GLY A 242 CYS A 285 SITE 2 AC2 8 ARG A 286 HOH A 676 HOH A 694 HOH A 708 CRYST1 64.140 64.140 165.850 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015591 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015591 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006030 0.00000